AlphaFold predicted structure
SLC9A6 · Q92581

Mean pLDDT
70.6/ 100
Confident
701 residues
Confidence breakdown
- Very high(≥ 90)26%
- Confident(70–90)38%
- Low(50–70)14%
- Very low(< 50)23%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 9 member A6
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Ataxia and cerebellar anomalies - narrow panel
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)DDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesEarly onset or syndromic epilepsy
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Hereditary ataxia
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Hereditary ataxia with onset in adulthood
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Intellectual disability
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Severe microcephaly
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Adult onset neurodegenerative disorder
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)+2 more panels — install the extension to see the full list inline on any page.
Christianson syndrome
Intellectual disability
hereditary disease
microcephaly
Angelman syndrome
neurodegenerative disease
Seizure
Global developmental delay
Sleep disturbance
Recurrent respiratory infections
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Sodium/hydrogen exchanger 6
Endosomal Na(+), K(+)/H(+) antiporter (PubMed:15522866, PubMed:28635961, PubMed:31676550, PubMed:32277048). Mediates the electroneutral exchange of endosomal luminal H(+) for a cytosolic Na(+) or K(+). By facilitating proton efflux, SLC9A6 counteracts the acidity generated by vacuolar (V)-ATPase, thereby limiting luminal acidification. Responsible for alkalizing and maintaining the endosomal pH, and consequently in, e.g., endosome maturation and trafficking of recycling endosomal cargo (PubMed:15522866, PubMed:28635961, PubMed:31676550, PubMed:32277048). Plays a critical role during neurodevelopment by regulating synaptic development and plasticity (By similarity). Implicated in the maintenance of cell polarity in a manner that is dependent on its ability to modulate intravesicular pH (PubMed:20130086). Regulates intracellular pH in some specialized cells, osteoclasts and stereocilia where this transporter localizes to the plasma membrane (By similarity)
SLC9A6 · Q92581

Mean pLDDT
70.6/ 100
Confident
701 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0